Informing the delivery of modern therapies for therapies improving cardiorenal outcomes for patients with type 2 diabetes

Per clinical guidelines, patients with Type 2 diabetes and certain co-morbidities should initiate modern glucose-controlling therapies that also reduce the risk of cardiovascular and renal adverse events, such as GLP-1 RA and SGLT2i medications. But many indicated patients have not initiated these therapies, in part because some primary care doctors are uncomfortable with the complex clinical considerations for initiating these therapies. Since 2022, the DECIDE-CV clinic at the McGill University Health Centre has used an innovative “synchronized care” approach, in which three specialists meet with patients at the same time to facilitate quick and safe initiation of guideline-directed therapies. In this project, an intern will use simulation modelling and economic evaluation methods to evaluate the DECIDE-CV clinic model, quantifying the health-economic impact and the long-term clinical benefits. This analysis will inform decisions to sustain, expand and/or modify the DECIDE-CV clinic at the MUHC. This project will also provide data to support other health systems that are considering ways to improve treatment for multimorbid patients with Type 2 diabetes.

Faculty Supervisor:

Alton Russell;Abhinav Sharma

Student:

Partner:

McGill University Health Centre Foundation;McGill University Health Centre

Discipline:

Mathematics

Sector:

Health and Related Sciences & Technology

University:

McGill University

Program: